Skip to content

News Category: Health & Medical

Hovione and GEA announce a strategic collaboration to advance Continuous Tableting

By asianet

Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s engineering expertise with Hovione´s development and manufacturing experience and both parties commit to partner to accelerate the adoption of Continuous Tableting technology. The advantages of continuous over batch manufacturing … Continued

Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH(R) System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

By asianet

Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems’ CELLSEARCH(R) System and the CELLSERCH(R) Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with Multiple Myeloma (MM) even at asymptomatic precursor stages /PRNewswire/ — Menarini Silicon Biosystems, a pioneer of liquid biopsy and single … Continued

Lost childhood: a ‘tight-knit’ network to combat abuse and distress

By asianet

On Radar takes off, the first meeting of the Think Tank of Fondazione Internazionale Menarini Setting real changes in motion through dialogue among experts in order to tackle the unresolved issues of juvenile distress. This was the topic addressed during the first meeting of the ‘On Radar’ Think Tank of Fondazione Internazionale Menarini held in … Continued

Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH’s Blood

By asianet

Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients’ immune dysregulation and deficiency The peer-reviewed publication heightens international understanding of APDS, a rare and recently characterized immunodeficiency Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces today that the … Continued

PGTG successfully develops SGF bone-derived factor to restore the skeletal system

By asianet

The bone-derived skeletal growth factor (SGF), jointly developed by a research facility under the direction of leading biochemist, academician and researcher Zhao Yufen and the Anhui-based research center of one of the world’s health industry leaders People’s GuoTai Group (PGTG), broke through the formula stability bottleneck after unremitting efforts over the last three years and … Continued

Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program

By asianet

–Practical, innovative functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience. Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, today announced that as part of its single platform rollout, its electronic … Continued

Turn Biotechnologies Changes Paradigm in Skin Rejuvenation

By asianet

— Data unveiled at four industry conferences suggest a single ERA treatment may be more effective than combination therapies used today — Biomarker analysis demonstrates ERA’s regenerative impact on fibroblast proliferation, collagen VII production — eTurna(TM) lipid-based delivery platform proves groundbreakingly effective at reaching targeted tissue — Company to present updated data during January webinar … Continued

Sai Life Sciences releases its Sustainability Report 2022

By asianet

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=sustainability-report-2022](CRO/ CDMO), today announced the release of its Sustainability Report 2022, which has been developed as per the Global Reporting Initiative (GRI) standards. With the theme ‘Organising for Sustainability Success’ the Report describes the company’s efforts in progressively reducing the knowing-doing gap by … Continued

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS

By asianet

— The Center at Rush University Will Be Directed By Dr. Elizabeth Berry-Kravis The Foundation for Angelman Syndrome Therapeutics (FAST) announced today a $5 million gift to establish the new clinical trial and translational research effort for rare neurodevelopmental disorders, a first-of-its-kind flagship center to be directed by Dr. Elizabeth Berry-Kravis. Named the Rush F.A.S.T. … Continued